Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Align Technology seeks cease-and-desist against ClearCorrect
The International Trade Commission reviews Align Technology’s patent infringement case against ClearCorrect, including the company’s cease-and-desist request.
2. Study: Presence of sales reps influences coronary stent selection, price
The presence of a sales rep can increase the per-case price of stenting by as much as $230, according to a study in the American Heart Journal.
1. More legal trouble for Fresenius
Legal troubles escalate for German healthcare giant Fresenius, which now faces a class action lawsuit over its dialysis drug GranuFlo.